The Effectiveness of At-home , In-office and Combined Dental Bleaching System :A Randomized Controlled Clinical Trial

Sponsor
Fujian Medical University (Other)
Overall Status
Completed
CT.gov ID
NCT05021965
Collaborator
(none)
68
1
4
8
8.6

Study Details

Study Description

Brief Summary

This randomized controlled clinical trial aimed to investigate the effectiveness of at-home , in-office and combined dental bleaching system.

Condition or Disease Intervention/Treatment Phase
  • Procedure: different combined of tooth bleaching procedure
N/A

Detailed Description

The participants with at least one maxillary tooth demonstrating shade A3 or darker will be recruited and randomly allocated into 4 groups according to the different tooth bleaching protocol:at-home bleaching for group 1,in-office bleaching for group 2 ,combined bleaching for group 3 and group 4.Participates in group 1 will receive two weeks of at-home tooth bleaching (Lasts 14 days and at least 8 hours every day )with 10% Carbamide peroxide(Opalescence PF 10%) , group 2 will receive two sessions (with a 1- week interval )of in-office tooth bleaching with 40% hydrogen peroxide (Opalescence Boost PF 40%),group 3 will receive one week of at-home tooth bleaching (Lasts 7 days and at least 8 hours every day )and then the eighth day receive one session of in-office tooth bleaching , group 4 receive one session of in-office bleaching and lasts 7 days at-home bleaching start on the eighth day . Colour parameters (CIE L*, a*, b*) will be measured with a spectrophotometer (Vita Easyshade Advance 4.0) at baseline (T1), after the first bleaching session (T2), after the second bleaching session (T3), 1 month after the completion of bleaching (T4). The colour differences (ΔE) and Tooth sensitivity (TS) will also be calculated. The data will be statistically analysed through repeated ANOVA and Tukey's test (α = 0.05).

Study Design

Study Type:
Interventional
Actual Enrollment :
68 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Double (Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Effectiveness of At-home , In-office and Combined Dental Bleaching System :A Randomized Controlled Clinical Trial
Actual Study Start Date :
Jul 15, 2021
Actual Primary Completion Date :
Jan 5, 2022
Actual Study Completion Date :
Mar 14, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: group 1: have two weeks of at-home tooth bleaching

Participants will receive two weeks of at-home tooth bleaching with 10% Carbamide peroxide(Opalescence PF 10%) for the maxillary anterior teeth.

Procedure: different combined of tooth bleaching procedure
The participants will be randomly allocated into 4 groups and receive different kind of tooth bleaching protocol.

Experimental: group 2 : have two sessions of in-office tooth bleaching

Participants will receive two sessions(with a 1- week interval ) of in-office tooth bleaching with 40% hydrogen peroxide (Opalescence Boost PF 40%)for the maxillary anterior teeth.

Procedure: different combined of tooth bleaching procedure
The participants will be randomly allocated into 4 groups and receive different kind of tooth bleaching protocol.

Experimental: group 3 : one week of at-home and then have one session of in-office tooth bleaching

Participants will receive one week of at-home tooth bleaching with 10% Carbamide peroxide(Opalescence PF 10%) and then receive one session of in-office tooth bleaching with 40% hydrogen peroxide (Opalescence Boost PF 40%)for the maxillary anterior teeth.

Procedure: different combined of tooth bleaching procedure
The participants will be randomly allocated into 4 groups and receive different kind of tooth bleaching protocol.

Experimental: group 4 : one week of in-office and then have one session of at-home tooth bleaching

Participants will receive one session of in-office tooth bleaching with 40% hydrogen peroxide (Opalescence Boost PF 40%) and a week later receive one week of at-home tooth bleaching with 10% Carbamide peroxide(Opalescence PF 10%)for the maxillary anterior teeth.

Procedure: different combined of tooth bleaching procedure
The participants will be randomly allocated into 4 groups and receive different kind of tooth bleaching protocol.

Outcome Measures

Primary Outcome Measures

  1. Change in tooth colour [six weeks]

    Colour parameters (CIE L*, a*, b*) will be measured with a spectrophotometer (Vita Easyshade Advance 4.0). The color alteration after each session will be given by the differences between the values obtained at the sessions and the baseline (∆E).

Secondary Outcome Measures

  1. Tooth sensitivity evaluation [two weeks]

    Using the visual analogue scale (VAS) record the Tooth sensitivity (TS) throughout the entire treatment

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • patients between 18 and 30 years of age, with fully erupted upper and lower incisors and canines without dental or periodontal disease or restorations, and with at least one maxillary tooth presenting color score A3 or darker, as measured with the Vita Classical guide (Vita Zahnfabrik, Bad Sa # ckingen, Germany) ordered by brightness
Exclusion Criteria:
  • patients with systemic diseases or oral mucosal disorders, previous bleaching treatment, patients undergoing orthodontic treatment, pregnant or lactating women , people with known allergy to the product ingredients, smokers, and alcohol abusers, had severe internal tooth discoloration (e.g. tetracycline stains), had bruxism or any other pathology that could cause TS (such as gingival recession or dentin exposure).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fujian Medical University Fuzhou Fujian China 350004

Sponsors and Collaborators

  • Fujian Medical University

Investigators

  • Principal Investigator: Hao Yu, PhD, Fujian Medical University, China

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hao Yu, vice dean of school and hospital of stomatology, Fujian Medical University
ClinicalTrials.gov Identifier:
NCT05021965
Other Study ID Numbers:
  • 20210715
First Posted:
Aug 26, 2021
Last Update Posted:
May 26, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of May 26, 2022